Venture capital and small business finance firm Advantage Capital Partners has been awarded a USD80 million allocation in the highly competitive federal New Markets Tax Credit program. This latest allocation brings the firm’s total awards since the program began in 2002 to USD524 million. Through prior state and federal New
Catella has acted as adviser and arranger for Sefyr Värme AB, the parent company of the district heating company Värmevärden AB, in the issue of a senior secured note in excess of SEK 900 million, directed at selected Nordic institutional investors. The bond carries a 7% coupon and has a
Halfpenny Technologies has secured USD2.25 million in venture capital funding co-led by Connecticut-based Vital Financial and Philadelphia-based Emerald Stage2 Ventures. Existing investors including Pennsylvania-based Osage Venture Partners, New York-based Milestone Venture Partners, and LORE Associates, a Philadelphia-based angel, also participated in the round. "We are very pleased to have the
Agribusiness and food company Bunge Limited is to acquire Climate Change Capital Limited (CCCG), a UK-regulated sustainable asset manager and advisor.

 The transaction was approved by the UK’s Financial Services Authority (FSA) on 20 February, 2012, and CCCG has obtained the required shareholder approvals to proceed. The transaction is expected
Blackstar has entered into a conditional agreement for the sale of 72,989,078 ordinary shares in Litha Healthcare Group Limited to Paladin Labs Inc. The Disposal, for a cash consideration of GBP16.6 million, represents 50% of Blackstar’s interest in Litha and equates to ZAR2.75 per Litha share. On completion, the Disposal
High Road Capital Partners’ portfolio company Advanced Sleep Medicine Services, Inc has completed the acquisition of Pacific Sleep Medicine Services, a provider of sleep disorder diagnostic services with laboratory facilities throughout Southern California. The acquisition closed on 17 February, 2012. Pacific Sleep will become part of Advanced Sleep’s existing
Ceptaris Therapeutics, Inc, a privately held specialty pharmaceutical company, has secured USD15 million in venture debt financing from Silicon Valley Bank and Oxford Finance. The New Drug Application (NDA) for Ceptaris’ drug candidate, mechlorethamine gel, is currently undergoing review by the US Food and Drug Administration (FDA) for the treatment
A record number of private equity add-on deals were completed in 2011 and the upward turn in transactions of this type is continuing into 2012, according to date released by Preqin. While the number of deals of other types plummeted, the number of add-on deals completed during the downturn remained
Advent International and GS Capital Partners VI Fund, LP and certain of its affiliates have signed a definitive merger agreement to acquire TransUnion from its current stockholders, including Madison Dearborn Partners and the Pritzker family business interests. The transaction, which is expected to close late first quarter or early second
Capital Dynamics has held the final closing of Capital Dynamics Champion Ventures VII, a US-based venture program targeting top-tier US venture managers or pre-eminent international venture firms with strong US ties. The final closing of Capital Dynamics Champion Ventures VII ends a successful fundraising for CapitalDynamics’ US-based venture capital program
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
